Devy Deliyanti
Devy Deliyanti
Research Fellow, Monash University
Verified email at
Cited by
Cited by
NADPH oxidase, NOX1, mediates vascular injury in ischemic retinopathy
JL Wilkinson-Berka, D Deliyanti, I Rana, AG Miller, A Agrotis, R Armani, ...
Antioxidants & redox signaling 20 (17), 2726-2740, 2014
The retinal renin–angiotensin system: Roles of angiotensin II and aldosterone
JL Wilkinson-Berka, A Agrotis, D Deliyanti
Peptides 36 (1), 142-150, 2012
Inhibition of NOX1/4 with GKT137831: a potential novel treatment to attenuate neuroglial cell inflammation in the retina
D Deliyanti, JL Wilkinson-Berka
Journal of neuroinflammation 12, 1-13, 2015
Foxp3+ Tregs are recruited to the retina to repair pathological angiogenesis
D Deliyanti, DM Talia, T Zhu, MJ Maxwell, A Agrotis, JR Jerome, ...
Nature communications 8 (1), 748, 2017
Neovascularization is attenuated with aldosterone synthase inhibition in rats with retinopathy
D Deliyanti, AG Miller, G Tan, KJ Binger, AL Samson, JL Wilkinson-Berka
Hypertension 59 (3), 607-613, 2012
Nrf2 activation is a potential therapeutic approach to attenuate diabetic retinopathy
D Deliyanti, SF Alrashdi, SM Tan, C Meyer, KW Ward, JB de Haan, ...
Investigative Ophthalmology & Visual Science 59 (2), 815-825, 2018
The TACI receptor regulates T-cell-independent marginal zone B cell responses through innate activation-induced cell death
WA Figgett, K Fairfax, FB Vincent, MA Le Page, I Katik, D Deliyanti, ...
Immunity 39 (3), 573-583, 2013
Ebselen by modulating oxidative stress improves hypoxia-induced macroglial Müller cell and vascular injury in the retina
SM Tan, D Deliyanti, WA Figgett, DM Talia, JB De Haan, ...
Experimental eye research 136, 1-8, 2015
The role of reactive oxygen species in the pathogenesis and treatment of retinal diseases
TCW Chan, JLW Berka, D Deliyanti, D Hunter, A Fung, G Liew, A White
Experimental eye research 201, 108255, 2020
Nox (NADPH oxidase) 1, Nox4, and Nox5 promote vascular permeability and neovascularization in retinopathy
D Deliyanti, SF Alrashdi, RM Touyz, CR Kennedy, JC Jha, ME Cooper, ...
Hypertension 75 (4), 1091-1101, 2020
Angiotensin II and aldosterone in retinal vasculopathy and inflammation
JL Wilkinson-Berka, V Suphapimol, JR Jerome, D Deliyanti, MJ Allingham
Experimental eye research 187, 107766, 2019
Deleting the BAFF receptor TACI protects against systemic lupus erythematosus without extensive reduction of B cell numbers
WA Figgett, D Deliyanti, KA Fairfax, PS Quah, JL Wilkinson-Berka, ...
Journal of autoimmunity 61, 9-16, 2015
Inhibition of the nuclear receptor RORγ and interleukin-17A suppresses neovascular retinopathy: involvement of immunocompetent microglia
DM Talia, D Deliyanti, A Agrotis, JL Wilkinson-Berka
Arteriosclerosis, thrombosis, and vascular biology 36 (6), 1186-1196, 2016
Overcoming monocarboxylate transporter 8 (MCT8)-deficiency to promote human oligodendrocyte differentiation and myelination
JY Lee, MJ Kim, D Deliyanti, MF Azari, F Rossello, A Costin, G Ramm, ...
EBioMedicine 25, 122-135, 2017
Aliskiren reduces vascular pathology in diabetic retinopathy and oxygen-induced retinopathy in the transgenic (mRen-2)27 rat
JL Wilkinson-Berka, G Tan, KJ Binger, L Sutton, K McMaster, D Deliyanti, ...
Diabetologia 54, 2724-2735, 2011
Brain and retinal microglia in health and disease: an unrecognized target of the renin–angiotensin system
CA McCarthy, RE Widdop, D Deliyanti, JL Wilkinson‐Berka
Clinical and Experimental Pharmacology and Physiology 40 (8), 571-579, 2013
A potent Nrf2 activator, dh404, bolsters antioxidant capacity in glial cells and attenuates ischaemic retinopathy
D Deliyanti, JY Lee, S Petratos, CJ Meyer, KW Ward, JL Wilkinson-Berka, ...
Clinical Science 130 (15), 1375-1387, 2016
Effect of NADPH oxidase 1 and 4 blockade in activated human retinal endothelial cells
B Appukuttan, Y Ma, A Stempel, LM Ashander, D Deliyanti, ...
Clinical & Experimental Ophthalmology 46 (6), 652-660, 2018
Prorenin stimulates a pro‐angiogenic and pro‐inflammatory response in retinal endothelial cells and an M1 phenotype in retinal microglia
T Zhu, AG Miller, D Deliyanti, DR Berka, A Agrotis, DJ Campbell, ...
Clinical and Experimental Pharmacology and Physiology 42 (5), 537-548, 2015
Retinal Vasculopathy is reduced by dietary salt restriction: involvement of glia, ENaCα, and the renin–angiotensin–aldosterone system
D Deliyanti, R Armani, D Casely, WA Figgett, A Agrotis, ...
Arteriosclerosis, Thrombosis, and Vascular Biology 34 (9), 2033-2041, 2014
The system can't perform the operation now. Try again later.
Articles 1–20